Dr. Kernodle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1612 Primm Dr
Brentwood, TN 37027Phone+1 615-838-4380
Education & Training
Vanderbilt University Medical CenterFellowship, Infectious Disease, 1984 - 1987- Vanderbilt University Medical CenterResidency, Internal Medicine, 1981 - 1984
University of North Carolina at Chapel Hill School of MedicineClass of 1981
Certifications & Licensure
TN State Medical License 1985 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsProblems With Ascribing Between-Trial Differences in BCG Effectiveness to Sensitization With Environmental MycobacteriaDouglas S. Kernodle
Clinical Infectious Diseases. 2014-08-15 - 5 citationsA Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminishe...Carolyn Shoen, Michelle S. DeStefano, Cynthia C. Hager, Kyi-Toe Tham, Miriam Braunstein
Vaccines. 2013-01-11 - 4 citationsWarning: differences in the copy number of duplication unit 2 (DU2) within BCG Danish 1331 may influence findings involving genetically modified BCG Danish strains.Douglas S. Kernodle
Vaccine. 2012-09-14
Other
- US Patent 8,481,056 - Pro-apoptotic bacterial vaccines to enhance cellular immune responsesKernodle DS, Bochan MR
http://patentimages.storage.googleapis.com/pdfs/US8481056.pdf
Press Mentions
TB Vaccine May Become Effective AgainMay 21st, 2009
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
